Content about GlaxoSmithKline

March 18, 2011

With respect to the Type 2 diabetes drug Avandia, British drug maker GlaxoSmithKline has another medical study to worry about.

March 14, 2011

Members of the Consumer Healthcare Products Association last week elected Paul Sturman, president and general manager of Pfizer Consumer Healthcare, to chair the association’s board, the association announced Monday.

March 11, 2011

GlaxoSmithKline said it is establishing a dedicated team to support community pharmacists and other healthcare professionals.

March 11, 2011

A late-stage trial of a biologic treatment for Type 1 diabetes appears to have failed, according to results announced Friday.

March 10, 2011

The Food and Drug Administration has approved a treatment for lupus made by GlaxoSmithKline and Human Genome Sciences, the agency said Wednesday.

March 1, 2011

Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

February 28, 2011

The Food and Drug Administration has approved a GlaxoSmithKline drug for a rare blood disorder, GSK said Friday.

February 23, 2011

Use of amphetamines could increase the risk of Parkinson’s disease, according to a new study.

February 18, 2011

SUPPLIER NEWS — Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores. Valeant acquired the rights to nonophthalmic topical formulations of Zovirax (acyclovir) from GSK for $300 million through its Canadian subsidiary, Biovail Labs.



February 14, 2011

GlaxoSmithKline has changed prescribing information on the labeling for one of its Type 2 diabetes drugs to reflect new restrictions on the drug’s use, the drug maker said.

February 7, 2011

GlaxoSmithKline has received a license extension in Europe for its popular weight-loss pill Alli.

February 7, 2011

GlaxoSmithKline company Stiefel has made its popular acne wash formulations available for over-the-counter use.

February 3, 2011

US WorldMeds has announced a new treatment for migraines, the drug maker said Wednesday.

February 3, 2011

Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores.

February 2, 2011

GlaxoSmithKline on Wednesday announced its support for the Wounded Warrior Project and Victory Junction, a camp for children with special needs, through its analgesic powder brands, BC and Goody’s.

February 1, 2011

The Food and Drug Administration has turned down an application for an anti-obesity drug.

January 27, 2011

The Food and Drug Administration declined to approve a regulatory approval application from British drug maker GlaxoSmithKline concerning a cancer drug, GSK said Wednesday.

January 18, 2011

Colin Mackenzie has been appointed the new president of GlaxoSmithKline Consumer Healthcare North America. Mackenzie succeeds Roger Scarlett-Smith, who is relocating to London to become president of GSK Consumer Healthcare Europe.

January 17, 2011

Drug maker GlaxoSmithKline will take a legal charge of $3.4 billion related to its promotion of a controversial diabetes drug.

January 5, 2011

WASHINGTON — The Consumer Healthcare Products Association recently named GlaxoSmithKline veteran Janet Carter-Smith chair of the CHPA Retailer Liaison Steering Committee effective Jan. 1. Carter-Smith is the third chair of this committee, succeeding David Howenstine, VP customer and industry development at Pfizer Consumer Healthcare, whose term ended at the end of the year.

January 4, 2011

Generic drug maker Par Pharmaceutical has begun shipping its version of a treatment for heart rhythm problems, the company said Monday.

December 22, 2010

The European Food Safety Authority has granted GlaxoSmithKline a positive opinion for a health claim related to its "toothkind" drinks, according to BeverageDaily.com, an online news service.

December 16, 2010

GlaxoSmithKline will pay Impax Pharmaceuticals $11.5 million upfront to exclusively sell Impax's investigational Parkinson’s disease treatment.

December 14, 2010

GlaxoSmithKline on Monday announced its acquisition from Darwin Private Equity of Maxinutrition, a U.K. company that manufactures protein-enhanced functional nutrition products.

© 2014 Drug Store News. All Rights Reserved.